Featured news in The Life Sciences Report

3D Signatures Inc. (DXD:TSX.V; TDSGF:OTCQB; 3D0:FSE)
3D Signatures Inc. Announces Short Form Prospectus Offering to Raise Up to C$5 Million (7/19/2017)
view
 


Inovio Pharmaceuticals Inc. (INO:NASDAQ)
Inovio Announces Pricing of Public Offering of Common Stock (7/19/2017)
view
 


Celgene Corp. (CELG:NASDAQ)
The Zacks Analyst Blog Highlights: Apple, JPMorgan, Celgene, PayPal and Vertex Pharmaceuticals (7/19/2017)
view
 


ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
Announces Presentation of Data from Alzheimer’s Disease Program at AAIC 2017 (7/19/2017)
view
 


Caladrius Biosciences Inc. (CLBS:NASDAQ)
Caladrius Biosciences Announces that 50% of Subjects Have Been Treated in the Phase 2 Clinical Trial of CLBS03 for Type 1 Diabetes (7/19/2017)
view
 


Inovio Pharmaceuticals Inc. (INO:NASDAQ)
Inovio Announces Proposed Public Offering of Common Stock (7/18/2017)
view
 

Inovio Pharmaceuticals Inc. (INO:NASDAQ)
Today's Research Reports on Trending Tickers: Inovio Pharmaceuticals Inc. and Universal Display Corporation (7/19/2017)
view
 


Celgene Corp. (CELG:NASDAQ)
Celgene- Value in Cancer Treatments (7/17/2017)
view
 

Celgene Corp. (CELG:NASDAQ)
Top Stock Reports for Apple, JPMorgan & Celgene (7/18/2017)
view
 

Celgene Corp. (CELG:NASDAQ)
Amgen (AMGN) Gets CRL for Osteoporosis Drug Evenity's BLA (7/17/2017)
view
 

Celgene Corp. (CELG:NASDAQ)
5 CAR-T Stocks in Focus as NVS Drug Wins FDA Advisory Panel Vote (7/18/2017)
view
 


Amarantus BioScience Holdings Inc. (AMBS:OTCQB)
Avant Diagnostics Highlights Published Clinical Utility Data for Theralink® mTOR Pathway Activation Data Predicting Tamoxifen® and Other Endocrine Treatment Response in Estrogen Receptor Positive (ER+) Breast Cancer (7/18/2017)
view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
BrainStorm Announces Agreements with Mass. General Hospital and California Pacific Medical Center to Participate in Phase 3 Trial of NurOwn® in ALS (7/18/2017)
view